OncoPan(®): An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma

Pancreatic cancer has a high morbidity and mortality with the majority being PC ductal adenocarcinomas (PDAC). Whole genome sequencing provides a wide description of genomic events involved in pancreatic carcinogenesis and identifies putative biomarkers for new therapeutic approaches. However, curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibiletti, Maria Grazia, Carnevali, Ileana, Pensotti, Valeria, Chiaravalli, Anna Maria, Facchi, Sofia, Volorio, Sara, Mariette, Frederique, Mariani, Paolo, Fortuzzi, Stefano, Pierotti, Marco Alessandro, Sessa, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138989/
https://www.ncbi.nlm.nih.gov/pubmed/35625944
http://dx.doi.org/10.3390/biomedicines10051208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138989/
https://www.ncbi.nlm.nih.gov/pubmed/35625944
http://dx.doi.org/10.3390/biomedicines10051208

Ejemplares similares